Literature DB >> 21532810

Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach.

Marilyn Huang1, Charlotte Sun, Stephanie Boyd-Rogers, Jennifer Burzawa, Andrea Milbourne, Elizabeth Keeler, Rebecca Yzquierdo, Patrick Lynch, Susan K Peterson, Karen Lu.   

Abstract

BACKGROUND: Endometrial and colorectal cancers are the most common cancers in Lynch syndrome. Consensus guidelines recommend annual endometrial biopsy (EMB) and regular colonoscopies. We assessed the feasibility of concurrently performing EMB and colonoscopy and evaluated women's perception of pain, satisfaction, and acceptability.
METHODS: From July 2002 to December 2009, women who had a gene mutation for Lynch syndrome, met the Amsterdam II criteria, or had a high-risk situation that required screening were prospectively enrolled. After conscious sedation, the procedures were sequentially performed. Patients completed pre- and postprocedure questionnaires assessing pain, level of satisfaction, and acceptability. The Wilcoxon rank test and Mann-Whitney test were used to compare pain scores.
RESULTS: Forty-two women completed the study. Median age was 37 years (range, 25 to 73). Nineteen had previously had an EMB in the office setting. Women reported significantly lower median levels of pain in the combined procedure compared with previous office setting biopsies (P < .001). Regardless of parity, women reported significantly less pain for an EMB as part of the combined screen compared with an office EMB (parous, P = .003; nulliparous, P = .026). Women also reported a high level of satisfaction and more convenience in the combined procedure. All participants preferred combined to separately scheduled procedures and would recommend the combined procedure to their relatives.
CONCLUSION: Combined colon and endometrial cancer screening is a patient-centered approach that is feasible, acceptable, and may improve adherence to Lynch syndrome screening recommendations.

Entities:  

Year:  2011        PMID: 21532810      PMCID: PMC3014510          DOI: 10.1200/JOP.2010.000038

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  17 in total

1.  Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Karen H Lu; Mai Dinh; Wendy Kohlmann; Patrice Watson; Jane Green; Sapna Syngal; Prathap Bandipalliam; Lee-May Chen; Brian Allen; Peggy Conrad; Jonathan Terdiman; Charlotte Sun; Molly Daniels; Thomas Burke; David M Gershenson; Henry Lynch; Patrick Lynch; Russell R Broaddus
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

Review 2.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

3.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

4.  The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis.

Authors:  F P Dijkhuizen; B W Mol; H A Brölmann; A P Heintz
Journal:  Cancer       Date:  2000-10-15       Impact factor: 6.860

5.  The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.

Authors:  Isis Dove-Edwin; Dominique Boks; Sheila Goff; Gemma G Kenter; Robert Carpenter; Hans F A Vasen; Huw J W Thomas
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

Review 6.  Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.

Authors:  Noralane M Lindor; Gloria M Petersen; Donald W Hadley; Anita Y Kinney; Susan Miesfeldt; Karen H Lu; Patrick Lynch; Wylie Burke; Nancy Press
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

7.  Decrease in mortality in Lynch syndrome families because of surveillance.

Authors:  Andrea E de Jong; Yvonne M C Hendriks; Jan H Kleibeuker; Sybrand Y de Boer; Annemieke Cats; Gerrit Griffioen; Fokko M Nagengast; Frits G Nelis; Matti A Rookus; Hans F A Vasen
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

Review 8.  Pain control in outpatient hysteroscopy.

Authors:  Jun Yang; Beverley Vollenhoven
Journal:  Obstet Gynecol Surv       Date:  2002-10       Impact factor: 2.347

9.  Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.

Authors:  Heikki J Järvinen; Laura Renkonen-Sinisalo; Katja Aktán-Collán; Päivi Peltomäki; Lauri A Aaltonen; Jukka-Pekka Mecklin
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

10.  Gynecologic screening in hereditary nonpolyposis colorectal cancer.

Authors:  Fleur E M Rijcken; Marian J E Mourits; Jan H Kleibeuker; Harry Hollema; Ate G J van der Zee
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

View more
  9 in total

1.  Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome.

Authors:  Denise R Nebgen; Karen H Lu; Sue Rimes; Elizabeth Keeler; Russell Broaddus; Mark F Munsell; Patrick M Lynch
Journal:  Gynecol Oncol       Date:  2014-08-19       Impact factor: 5.482

2.  Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.

Authors:  A M Burton-Chase; S R Hovick; S K Peterson; S K Marani; S W Vernon; C I Amos; M L Frazier; P M Lynch; E R Gritz
Journal:  Clin Genet       Date:  2013-03       Impact factor: 4.438

Review 3.  Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.

Authors:  Kathleen F Mittendorf; Sarah Knerr; Tia L Kauffman; Nangel M Lindberg; Katherine P Anderson; Heather Spencer Feigelson; Marian J Gilmore; Jessica Ezzell Hunter; Galen Joseph; Stephanie A Kraft; Jamilyn M Zepp; Sapna Syngal; Benjamin S Wilfond; Katrina A B Goddard
Journal:  JCO Precis Oncol       Date:  2021-11-03

Review 4.  Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention.

Authors:  Karen H Lu; Molly Daniels
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Endometrial and ovarian cancer in lynch syndrome.

Authors:  Marta Ann Crispens
Journal:  Clin Colon Rectal Surg       Date:  2012-06

6.  Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.

Authors:  Tadeusz Dębniak; Tomasz Gromowski; Rodney J Scott; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Grzegorz Kurzawski; Dagmara Dymerska; Bohdan Górski; Katarzyna Paszkowska-Szczur; Cezary Cybulski; Pablo Serrano-Fernandez; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2015-01-16       Impact factor: 2.857

7.  Influencing Cancer Screening Participation Rates-Providing a Combined Cancer Screening Program (a 'One Stop' Shop) Could Be a Potential Answer.

Authors:  Amanda Bobridge; Kay Price; Tiffany K Gill; Anne W Taylor
Journal:  Front Oncol       Date:  2017-12-13       Impact factor: 6.244

8.  Pain evaluation during gynaecological surveillance in women with Lynch syndrome.

Authors:  Jorien Helder-Woolderink; Geertruida de Bock; Harry Hollema; Magda van Oven; Marian Mourits
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

9.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Authors:  Hans F A Vasen; Ignacio Blanco; Katja Aktan-Collan; Jessica P Gopie; Angel Alonso; Stefan Aretz; Inge Bernstein; Lucio Bertario; John Burn; Gabriel Capella; Chrystelle Colas; Christoph Engel; Ian M Frayling; Maurizio Genuardi; Karl Heinimann; Frederik J Hes; Shirley V Hodgson; John A Karagiannis; Fiona Lalloo; Annika Lindblom; Jukka-Pekka Mecklin; Pal Møller; Torben Myrhoj; Fokko M Nagengast; Yann Parc; Maurizio Ponz de Leon; Laura Renkonen-Sinisalo; Julian R Sampson; Astrid Stormorken; Rolf H Sijmons; Sabine Tejpar; Huw J W Thomas; Nils Rahner; Juul T Wijnen; Heikki Juhani Järvinen; Gabriela Möslein
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.